Kenneth E. Pengel

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Pathological complete remission (pCR) of estrogen receptor (ER)-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer is rarely achieved after neoadjuvant chemotherapy (NAC). In addition, the prognostic value of pCR for this breast cancer subtype is limited. We explored whether response evaluation by magnetic resonance imaging(More)
  • 1